KRYS CIK: 1711279

Krystal Biotech, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.44
FY22:
0.38
FY23:
0.59
FY24:
0.74
FY25:
1.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.18
FY22:
0.17
FY23:
0.23
FY24:
0.31
FY25:
0.31
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.63
FY22:
0.56
FY23:
0.82
FY24:
1.06
FY25:
1.33

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.03
FY23:
0.03
FY24:
0.10
FY25:
0.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.59
FY22:
0.52
FY23:
0.78
FY24:
0.95
FY25:
1.22
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.63
FY22:
0.56
FY23:
0.82
FY24:
1.06
FY25:
1.33

All amounts in billions USD Data source:SEC EDGAR